Our most recent announcements.
Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first and only Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, announced today it has joined the Decentralized Trials & Research Alliance (DTRA), an historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
Strategically located in Greater Philadelphia, the new property is the second location owned by Ancillare within the pharma corridor of the northeastern United States. The company plans to renovate the space to accommodate expansion of its core capabilities, including kitting, labeling, and Direct-to-Patient operations.
Christopher Calabretta, an accomplished procurement and operations executive, brings three decades of supply chain expertise to Ancillare’s leadership team.
Leading life sciences supply chain organization acquires NG BV, a Netherlands-based company authorized to procure, supply, and export medicinal products.
Meet with us at any of the industry tradeshows on our schedule to learn the latest on Clinical Trial Ancillary Supply Chain (CTASC™) Management.
Can't Meet with Us in Person This Year?
Tell us a little about your project or ancillary supply challenges, and we will set-up a complimentary consultation with our team.